Literature DB >> 19174417

Toll-like receptor 2 is critical for induction of Reg3 beta expression and intestinal clearance of Yersinia pseudotuberculosis.

R Dessein1, M Gironella, C Vignal, L Peyrin-Biroulet, H Sokol, T Secher, S Lacas-Gervais, J-J Gratadoux, F Lafont, J-C Dagorn, B Ryffel, S Akira, P Langella, G Nùñez, J-C Sirard, J Iovanna, M Simonet, M Chamaillard.   

Abstract

OBJECTIVE: Yersinia pseudotuberculosis causes ileitis and mesenteric lymphadenitis by mainly invading the Peyer's patches that are positioned in the terminal ileum. Whereas toll-like-receptor 2 (TLR2) controls mucosal inflammation by detecting certain microbiota-derived signals, its exact role in protecting Peyer's patches against bacterial invasion has not been defined.
DESIGN: Wild-type, Tlr2-, Nod2- and MyD88-deficient animals were challenged by Y pseudotuberculosis via the oral or systemic route. The role of microbiota in conditioning Peyer's patches against Yersinia through TLR2 was assessed by delivering, ad libitum, exogenous TLR2 agonists in drinking water to germ-free and streptomycin-treated animals. Bacterial eradication from Peyer's patches was measured by using a colony-forming unit assay. Expression of cryptdins and the c-type lectin Reg3 beta was quantified by quantitative reverse transcriptase polymerase chain reaction analysis.
RESULTS: Our data demonstrated that Tlr2-deficient mice failed to limit Yersinia dissemination from the Peyer's patches and succumbed to sepsis independently of nucleotide-binding and oligomerisation domain 2 (NOD2). Recognition of both microbiota-derived and myeloid differentiation factor 88 (MyD88)-mediated elicitors was found to be critically involved in gut protection against Yersinia-induced lethality, while TLR2 was dispensable to systemic Yersinia infection. Gene expression analyses revealed that optimal epithelial transcript level of the anti-infective Reg3 beta requires TLR2 activation. Consistently, Yersinia infection triggered TLR2-dependent Reg3 beta expression in Peyer's patches. Importantly, oral treatment with exogenous TLR2 agonists in germ-free animals was able to further enhance Yersinia-induced expression of Reg3 beta and to restore intestinal resistance to Yersinia. Lastly, genetic ablation of Reg3 beta resulted in impaired clearance of the bacterial load in Peyer's patches.
CONCLUSIONS: TLR2/REG3 beta is thus an essential component in conditioning epithelial defence signalling pathways against bacterial invasion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19174417     DOI: 10.1136/gut.2008.168443

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  49 in total

1.  The bactericidal activity of the C-type lectin RegIIIβ against Gram-negative bacteria involves binding to lipid A.

Authors:  Tsuyoshi Miki; Otto Holst; Wolf-Dietrich Hardt
Journal:  J Biol Chem       Date:  2012-08-15       Impact factor: 5.157

2.  Innate Recognition of the Microbiota by TLR1 Promotes Epithelial Homeostasis and Prevents Chronic Inflammation.

Authors:  Karishma Kamdar; Andrew M F Johnson; Denise Chac; Kalisa Myers; Vrishika Kulur; Kyle Truevillian; R William DePaolo
Journal:  J Immunol       Date:  2018-05-23       Impact factor: 5.422

Review 3.  Shifting the balance: antibiotic effects on host-microbiota mutualism.

Authors:  Benjamin P Willing; Shannon L Russell; B Brett Finlay
Journal:  Nat Rev Microbiol       Date:  2011-02-28       Impact factor: 60.633

Review 4.  Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota.

Authors:  C T Peterson; V Sharma; L Elmén; S N Peterson
Journal:  Clin Exp Immunol       Date:  2015-03       Impact factor: 4.330

5.  Flagellin-Mediated Protection against Intestinal Yersinia pseudotuberculosis Infection Does Not Require Interleukin-22.

Authors:  Rémi Porte; Laurye Van Maele; Natalia Muñoz-Wolf; Benoit Foligné; Laure Dumoutier; Julien Tabareau; Delphine Cayet; Pierre Gosset; Nicolas Jonckheere; Isabelle Van Seuningen; José A Chabalgoity; Michel Simonet; Mohamed Lamkanfi; Jean-Christophe Renauld; Jean-Claude Sirard; Christophe Carnoy
Journal:  Infect Immun       Date:  2017-01-26       Impact factor: 3.441

Review 6.  G.I. pros: Antimicrobial defense in the gastrointestinal tract.

Authors:  Lawton K Chung; Manuela Raffatellu
Journal:  Semin Cell Dev Biol       Date:  2018-02-12       Impact factor: 7.727

Review 7.  Role of the gut microbiota in immunity and inflammatory disease.

Authors:  Nobuhiko Kamada; Sang-Uk Seo; Grace Y Chen; Gabriel Núñez
Journal:  Nat Rev Immunol       Date:  2013-05       Impact factor: 53.106

8.  The art of targeting gut microbiota for tackling human obesity.

Authors:  Marisol Aguirre; Koen Venema
Journal:  Genes Nutr       Date:  2015-05-20       Impact factor: 5.523

Review 9.  Microbiota-mediated colonization resistance against intestinal pathogens.

Authors:  Charlie G Buffie; Eric G Pamer
Journal:  Nat Rev Immunol       Date:  2013-10-07       Impact factor: 53.106

10.  A Single Bacterial Immune Evasion Strategy Dismantles Both MyD88 and TRIF Signaling Pathways Downstream of TLR4.

Authors:  Charles V Rosadini; Ivan Zanoni; Charlotte Odendall; Erin R Green; Michelle K Paczosa; Naomi H Philip; Igor E Brodsky; Joan Mecsas; Jonathan C Kagan
Journal:  Cell Host Microbe       Date:  2015-12-09       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.